UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.07B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Costco
COST
|
+$252M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Advanced Micro Devices
AMD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$274M |
| 2 |
UnitedHealth
UNH
|
+$207M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$204M |
| 4 |
Home Depot
HD
|
+$203M |
| 5 |
Qualcomm
QCOM
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 11.18% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZUO
1626
DELISTED
Zuora, Inc.
ZUO
| $2.05M | ﹤0.01% |
225,246
+26,182
| +13% | +$228K |
|
|
DVAX
1627
DELISTED
Dynavax Technologies
DVAX
| $2.05M | ﹤0.01% |
165,432
| – | – |
|
|
PYCR
1628
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.05M | ﹤0.01% |
105,571
-5,416
| -5% | -$108K |
|
1629
Recursion Pharmaceuticals
RXRX
$1.76B
| $2.05M | ﹤0.01% |
205,769
-21,104
| -9% | -$235K |
|
|
RNAM
1630
DELISTED
Avidity Biosciences
RNAM
| $2.05M | ﹤0.01% |
80,298
-10,867
| -12% | -$170K |
|
1631
LegalZoom.com
LZ
$961M
| $2.05M | ﹤0.01% |
153,575
+8,590
| +6% | +$98.9K |
|
1632
The Greenbrier Companies
GBX
$1.44B
| $2.04M | ﹤0.01% |
39,244
+8,928
| +29% | +$429K |
|
1633
International Seaways
INSW
$4.47B
| $2.04M | ﹤0.01% |
38,411
+1,770
| +5% | +$91.7K |
|
1634
Helios Technologies
HLIO
$2.74B
| $2.04M | ﹤0.01% |
45,566
+5,664
| +14% | +$243K |
|
1635
Utz Brands
UTZ
$1.25B
| $2.03M | ﹤0.01% |
110,129
| – | – |
|
1636
Arbor Realty Trust
ABR
$1.01B
| $2.03M | ﹤0.01% |
152,898
| – | – |
|
1637
Atlanta Braves Holdings Series B
BATRK
$3.22B
| $2.03M | ﹤0.01% |
51,862
-3,200
| -6% | -$126K |
|
1638
Navient
NAVI
$812M
| $2.02M | ﹤0.01% |
116,248
-28,293
| -20% | -$477K |
|
1639
Lindsay Corp
LNN
$1.18B
| $2.02M | ﹤0.01% |
17,137
+1,841
| +12% | +$229K |
|
1640
Fastly Inc
FSLY
$4.43B
| $2.01M | ﹤0.01% |
154,895
| – | – |
|
1641
WaFd
WAFD
$2.77B
| $2.01M | ﹤0.01% |
69,073
-2,834
| -4% | -$81.7K |
|
1642
Alphatec Holdings
ATEC
$1.47B
| $1.99M | ﹤0.01% |
144,621
+244
| +0.2% | +$3.62K |
|
1643
Myriad Genetics
MYGN
$309M
| $1.99M | ﹤0.01% |
93,371
| – | – |
|
1644
Northwest Bancshares
NWBI
$2.27B
| $1.98M | ﹤0.01% |
169,932
-7,962
| -4% | -$94.4K |
|
1645
StepStone Group
STEP
$3.76B
| $1.98M | ﹤0.01% |
55,265
| – | – |
|
|
BWIN
1646
Baldwin Insurance Group
BWIN
$2.78B
| $1.96M | ﹤0.01% |
67,565
| – | – |
|
1647
Cal-Maine
CALM
$3.85B
| $1.95M | ﹤0.01% |
33,113
| – | – |
|
1648
Asana
ASAN
$2.12B
| $1.95M | ﹤0.01% |
125,568
+13,216
| +12% | +$237K |
|
1649
Wabash National
WNC
$511M
| $1.94M | ﹤0.01% |
64,733
+11,061
| +21% | +$292K |
|
1650
Sotera Health
SHC
$5.39B
| $1.94M | ﹤0.01% |
161,372
| – | – |
|
Similar funds
UBS AM's Q1 2024 Portfolio in Review
As of Q1 2024, UBS AM held 2,593 positions worth $281B, up 11% from $254B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.9%. UBS AM opened 53 new positions and exited 73, leaving the 2,593-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2024 buy was iShares Core MSCI EAFE ETF: 57,224,039 shares worth $4.25B.
- UBS AM added most to Costco in Q1 2024, an estimated $252M increase.
- UBS AM's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $274M.
- UBS AM fully exited Splunk Inc in Q1 2024, selling an estimated $204M.
- UBS AM's ten largest holdings make up 27% of its $281B portfolio in Q1 2024.
- UBS AM opened 53 new positions and closed 73 in Q1 2024.
- UBS AM's portfolio value rose 11% quarter-over-quarter to $281B.
Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.